Rezolute RZLT
NASDAQ RZLT
$4.07 +0.05 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Rezolute (RZLT) EBIT Margin (2019 - 2020)

Updated

Rezolute's EBIT Margin came in at -120766.67% for fiscal Q1 2021 (quarter ended Sep 30, 2020), down 49726.67 percentage points from the prior quarter.

Analysis

Rezolute (RZLT) EBIT Margin (2019 - 2020) Analysis & Trends

Over the trailing twelve months to Sep 30, 2020, Rezolute reported EBIT Margin of -20614.13%; for FY2020 (ended Jun 30, 2020), it came in at -10915.43%, up 31615.72 percentage points from FY2019.

  • Going back by fiscal year, EBIT Margin was -42531.15% in FY2019.
  • The fiscal Q1 2021 figure represents the lowest quarterly EBIT Margin since fiscal Q3 2019.
  • Business Quant data shows RZLT's EBIT Margin at -71040.00% (Q4 2020), -16900.00% (Q3 2020) and -12444.44% (Q2 2020) in the three fiscal quarters before Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Rezolute 388.82 Mn -62.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -120,766.67%
Jun 30, 2020 -71,040.00%
Mar 31, 2020 -16,900.00%
Dec 31, 2019 -12,444.44%
Jun 30, 2019 -6,497.96%
Mar 31, 2019 -141,975.00%
API Access

Rezolute EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=RZLT&period=max&api_key=YOUR_API_KEY